Electrical safety methods, devices, and systems for medical treatment devices

US10300221B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10300221-B2
Application numberUS-201715717477-A
CountryUS
Kind codeB2
Filing dateSep 27, 2017
Priority dateJun 8, 2011
Publication dateMay 28, 2019
Grant dateMay 28, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Systems, methods, and devices can detect a dangerous or adverse condition or anticipated condition that indicates an undesirable amount of electric current in a patient-connected tube providing fluid to a patient. The fluid flow to the patient is stopped responsive to the detection. Stoppage of fluid flow to the patient can reduce or prevent electric current in the fluid from reaching a patient, flowing through the patient to ground, and/or continuing to flow through the patient.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for protecting a patient from an electrical source of a treatment device, the method comprising: connecting the patient to a treatment device by a fluid circuit in which a leakage current is induced by capacitive and/or inductive coupling of the fluid circuit with the treatment device over multiple paths to the patient; providing conductive elements adjacent the fluid circuit for each of the multiple paths such that they are capacitively coupled to the fluid circuit, wherein the conductive element is electrically isolated from a fluid carried by said fluid circuit and the fluid carried by the fluid circuit is conductive; detecting an inducing of a voltage in said conductive elements and detecting a magnitude of the sum of the currents in said multiple paths indicated by voltages in said capacitive and/or inductive coupling; and in response to the sum interrupting a normal operation of the treatment device effective to reduce said leakage current, outputting a human perceptible output indicating the magnitude of the voltage, or interrupting continuity of said fluid between the treatment device and a patient connector. 2. The method of claim 1 , wherein the conductive element is adjacent a tube of said fluid circuit. 3. The method of claim 2 , wherein the conductive element is a curved plate that wraps at least partly around the tube. 4. The method of claim 1 , wherein the conductive element is a metal clip. 5. The method of claim 1 , wherein the interrupting a normal operation includes closing a valve. 6. The method of claim 1 , wherein the interrupting a normal operation includes pinching a tube of said fluid circuit to isolate fluid in one portion of the fluid circuit with fluid in another portion of the fluid circuit so that current cannot be carried from the fluid in the one portion of the fluid circuit to the fluid in the another portion. 7. The method of claim 1 , wherein the fluid carried by the fluid circuit includes blood. 8. The method of claim 1 , wherein the fluid carried by the fluid circuit includes dialysate. 9. The method of claim 1 , wherein the treatment device includes an intravenous pump. 10. The method of claim 1 , wherein the treatment device includes a dialysis system. 11. The method of claim 1 , wherein the magnitude is responsive to the phases of the currents in said multiple paths.

Assignees

Inventors

Classifications

  • A61M1/14Primary

    Dialysis systems; Artificial kidneys; Blood oxygenators (semi-permeable membranes characterised by the material, manufacturing processes therefor B01D71/00){; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis} · CPC title

  • Plasmapheresis; Leucopheresis; Lymphopheresis (A61M1/3472 takes precedence) · CPC title

  • Removing constituents from donor blood and {storing or} returning remainder to body {, e.g. for transfusion} · CPC title

  • Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation {; Extra-corporeal blood circuits} · CPC title

  • Conductive materials, e.g. antistatic coatings for spark prevention · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10300221B2 cover?
Systems, methods, and devices can detect a dangerous or adverse condition or anticipated condition that indicates an undesirable amount of electric current in a patient-connected tube providing fluid to a patient. The fluid flow to the patient is stopped responsive to the detection. Stoppage of fluid flow to the patient can reduce or prevent electric current in the fluid from reaching a patient…
Who is the assignee on this patent?
Nxstage Medical Inc
What technology area does this patent fall under?
Primary CPC classification A61M1/14. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).